Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Acknowledgement of Commercial Support
This activity is supported by an educational grant from from Boehringer Ingelheim Pharmaceuticals, Inc.
This activity is held in conjunction with the ARRS 2019 Annual Meeting but is not part of the ARRS CME program. CME credit must be claimed separately through the accrediting provider. Attendance is open to ARRS Annual Meeting and Virtual Meeting registrants only.
An Interactive, Case-Based Discussion: Improving Outcomes in Progressive Fibrosing-Interstitial Lung Disease (PF-ILD) Through Early and Accurate Diagnosis
Hawaii Convention Center
1801 Kalakaua Ave
Honolulu, HI 96815
Lunch and Registration: 11:00 AM – 11:30 AM
Program: 11:30 AM – 12:30 PM
Progressive fibrosing-interstitial lung disease (PF-ILD) is a serious pulmonary disorder that can impact affected patients with significant morbidity and mortality. Diagnosis of PF-ILD is generally complicated because there are more than 100 forms of ILD described. Clinicians must be able to delineate the pathophysiologic mechanisms behind the various forms of PF-ILD, and identify associated pathological fibrosis patterns to promote earlier diagnosis for prompt intervention. Active collaboration with patients to address therapeutic options for these disorders includes potential enrollment in clinical trials for emerging therapies. With an ever-changing landscape for management of PF-ILDs, it is critical that clinicians be educated on all aspects of these disorders, including new pathways to improving patient management and optimizing overall outcomes. This interactive symposium is specifically designed to inform radiologists on early recognition, differential and accurate diagnosis, as well as the new and emerging treatments for patients with PF-ILDs.
Upon successful completion of this activity, you should be better prepared to:
- Identify key mechanisms underlying the various forms, clinical presentation, and management of PF-ILD
- Interpret radiographic patterns on high-resolution computed tomography to differentially diagnose ILDs, including idiopathic PF
- Improve ability to diagnose and differentiate PF-ILD earlier in the course of disease to allow more prompt intervention
- Discuss current and emerging treatments for management of the various forms of PF-ILD and their potential use in clinical practice
This educational program is directed toward all attendees of the American Roentgen Ray Society (ARRS) Annual Meeting, including radiologists.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Registration2 Ways to Register
- Online: click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701.
2 Clarke Drive
Cranbury, NJ 08512
Registration Fee - Free
For registration assistance, please email email@example.com, or call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.
ChairJoshua J. Solomon, MD
Associate Chief, Section of Critical Care
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.